Metabolic Syndrome and Selective Inflammatory Markers in Psoriatic Patients
The presented article studies the role of selected inflammatory and anti-inflammatory serum markers of psoriatic patients in the pathogenesis of metabolic syndrome (MS) and psoriasis. The study is based on the comparison between the group of psoriatic patients (74) and the control group (65). We fou...
Main Authors: | Simona Vachatova, Ctirad Andrys, Jan Krejsek, Miloslav Salavec, Karel Ettler, Vit Rehacek, Eva Cermakova, Andrea Malkova, Zdenek Fiala, Lenka Borska |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2016-01-01
|
Series: | Journal of Immunology Research |
Online Access: | http://dx.doi.org/10.1155/2016/5380792 |
Similar Items
-
Selected Inflammatory and Metabolic Markers in Psoriatic Patients Treated with Goeckerman Therapy
by: Katerina Kondelkova, et al.
Published: (2015-01-01) -
CC and CXC Chemokines Patterns in Psoriasis Determined by Protein Array Method Were Influenced by Goeckerman’s Therapy
by: David Pohl, et al.
Published: (2009-01-01) -
Serum Level of a Soluble Form of Endoglin (CD105) is Decreased after Goeckerman’s Therapy of Psoriasis
by: David Pohl, et al.
Published: (2011-01-01) -
Systemic Inflammation, Oxidative Damage to Nucleic Acids, and Metabolic Syndrome in the Pathogenesis of Psoriasis
by: Lenka Borska, et al.
Published: (2017-10-01) -
Health Risk of Occupational Exposure in Welding Processes II. Immunological Effects
by: Lenka Borská, et al.
Published: (2003-01-01)